Mark Fields, MPH, PhD
Associate Professor TermCards
About
Titles
Associate Professor Term
Appointments
Ophthalmology
Associate Professor on TermPrimary
Other Departments & Organizations
Education & Training
- Postdoctoral Research Fellow
- Columbia University in the City of New York (2011)
- MPH
- Columbia University in the City of New York, Mailman School of Public Health, Executive Masters of Healthcare Management (2010)
- PhD
- Medical College of Georgia (2007)
- BA
- Covenant College, Natural Science (2000)
Research
Publications
2019
Interactions of the choroid, Bruch's membrane, retinal pigment epithelium, and neurosensory retina collaborate to form the outer blood-retinal-barrier
Fields M, Del Priore LV, Adelman RA, Rizzolo LJ. Interactions of the choroid, Bruch's membrane, retinal pigment epithelium, and neurosensory retina collaborate to form the outer blood-retinal-barrier. Progress In Retinal And Eye Research 2019, 76: 100803. PMID: 31704339, DOI: 10.1016/j.preteyeres.2019.100803.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
2018
Culturing of Retinal Pigment Epithelial Cells on an <em>Ex Vivo</em> Model of Aged Human Bruch's Membrane
Cai H, Gong J, Del Priore L, Tezel T, Fields M. Culturing of Retinal Pigment Epithelial Cells on an Ex Vivo Model of Aged Human Bruch's Membrane. Journal Of Visualized Experiments 2018 DOI: 10.3791/57084-v.Peer-Reviewed Original Research
2012
The Eye as a Target Organ for Stem Cell Therapy
Fields M, Hwang J, Gong J, Cai H, Del Priore L. The Eye as a Target Organ for Stem Cell Therapy. Stem Cell Biology And Regenerative Medicine 2012, 1-29. DOI: 10.1007/978-1-4614-5493-9_1.Peer-Reviewed Original ResearchAge-related macular degenerationRetinal pigment epitheliumRetinal degenerative diseasesStem cell therapyCell therapyRetinitis pigmentosaDegenerative diseasesCurrent clinical trialsPromising therapeutic optionNature of pathologyViable clinical optionReplacement therapyTherapeutic optionsClinical trialsCell replacement therapyMacular degenerationRetinal disordersCellular disarrayPigment epitheliumTarget organsPharmaceutical treatmentClinical optionProgressive cellular dysfunctionRetinal degenerationTherapeutic interventions
News
Get In Touch
Contacts
Locations
300 George Street
Academic Office
Ste 8107A
New Haven, CT 06511
Business Office
203.737.6387300 George Street
Lab
Ste 8100
New Haven, CT 06511